Incremental Increases: Following the initial phase, the dose is gradually increased every four weeks, under the guidance of your healthcare provider (e.g., to 0.5 mg, then 1.0 mg, and potentially up to 2.4 mg for weight management, as seen with Wegovy, or 2.0 mg for type 2 diabetes, as with Ozempic)
Luckily, there are ways to enhance the results of GLP-1 medication to target visceral fat and support muscle preservation
If someone enjoys yerba mate and wants a gentle nudge toward appetite control, theres no harm in incorporating it as part of a comprehensive weight management strategy, Keatley says
The lipid-modifying effects should be considered as part of a broader cardiometabolic benefit profile rather than a primary indication for cholesterol management
IQVIA estimates that at least one in three people living with obesity worldwide resides in a country where semaglutide is available off-patent in 2026